(PharmaNewsWire.Com, September 23, 2017 ) Uterine cancer is one of most commonly prevailing malignant tumours that starts in the cells of the uterus and spreads to other parts of the body. Uterine cancer is mainly of two types such as uterine sarcoma and endometrial carcinoma. Till now more numbers of therapies have been evolved to manage uterine cancer types include surgery, chemotherapy, radiation therapy, immunotherapy, and hormone therapy.
Rising incidence of endometrial cancer in certain states of United States (Caucasians, Hawaiians, Japanese), increasing research to identify new therapeutic approaches, growing advancements in molecular diagnostics industry to support target specific therapies, and rising demand for effective & better therapy solutions are driving the growth of Uterine Cancer Therapeutics Market in North America. In addition, growing awareness among patients and presence of highly developed healthcare infrastructure are further fuelling the growth of Uterine Cancer Therapeutics Market in North America. However, stringent regulatory framework and unclear reimbursement policies are expected to limit the growth of Uterine Cancer Therapeutics market in North America.
North America Uterine Cancer Therapeutics market is broadly categorized into type and therapy. On the basis of type North America Uterine Cancer Therapeutics market is segmented into Uterine Sarcoma and Endometrial Carcinoma (Adenocarcinoma, Carcinosarcoma, Squamous cell carcinoma, & Others). Of these, Endometrial Carcinoma is expected to hold the major market share in the North America Uterine Cancer Therapeutics market. Based on therapy the market is segmented into Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, and Hormone Therapy.
On the basis of geography, the North America Uterine Cancer Therapeutics market is segmented into United States and Canada. Key market players in Uterine Cancer Therapeutics market such as Abbott Laboratories (U.S.), Ariad Pharmaceuticals, Inc. (U.S.), Becton, Dickinson and Company (U.S.), F. Hoffmann-La Roche AG (Switzerland), GlaxoSmithKline Plc (U.K.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Sanofi (France), Siemens Healthcare GmbH (Germany), and Takeda Pharmaceutical Company Ltd. (Japan).
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: